Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.

Oncology Territory Manager, Northcentral

Oncology Territory Manager, Southeast

Senior Travel & Expense Specialist

Senior Scientist I, Biological Sciences

Deciphera Pharmaceuticals

Senior Medical Director

Executive Assistant

Clinical Trial Associate

Clinical Research Assistant II

Clinical Research Assistant I

Social Committee Board Member

Research Intern

Summer Intern

Director, Chemical Development

Director, Technical Operations

Senior Principal Scientist

Senior Research Scientist

Process Development Scientist

Associate Director of Chemical Development

Principal Scientist I

Senior Manufacturing Chemist - Chemical Development

Research Scientist - Process Chemistry

Investigator - Process Chemistry

Investigator - Medicinal Chemistry

Principal Talent Partner (Via Bond)

Principal Talent Partner

Sr. Recruiter, Research and Development

Senior Technical Recruiter

Technical Recruiter

Manager, Talent Acquisition

Talent Acquisition Team Lead

Recruiter

HR Associate

Club Coordinator

Assistant Soccer Coach

Clinical Scientist, Senior Manager

Clinical Scientist, Manager

Nurse Practitioner

Registered Nurse

Intern

Senior Principal Investigator

Principal Investigator

Senior Scientist II

Senior Scientist

Postdoctoral Research Fellow

Graduate Research and Teaching Assistant

DNS Made Easy

Mimecast

Drupal

Pantheon

Amazon SES

SmartRecruiters

Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations, expanding the addressable patient population by offering one solution for many mutations. Our mission: defeat cancer resistance and provide people living with cancer the opportunity to experience longer, healthier and more active lives. We are advancing two potent, brain-penetrant clinical-stage programs: BDTX-1535, a fourth-generation EGFR inhibitor targeting non-small cell lung cancer (NSCLC) and glioblastoma (GBM) and BDTX-4933, a RAF inhibitor targeting KRAS, NRAS and BRAF alterations in NSCLC and other solid tumors.

Formulation and Product Development Intern/Co-op - Masters or PhD

Formulation and Product Development Intern/Co-op  - Master's or PhD

Black Diamond Therapeutics

Outlook

Microsoft Office 365

Sendgrid

Amazon AWS

New Relic

Corbus is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus' internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells.  We are tenacious and will keep pushing the known boundaries to make breakthroughs where others have not.

Director, Clinical Operations

Director, Clinical Operations (Metabolic/Obesity)

Senior Director/Director, Clinical Scientist

Senior Director/Director, Global Regulatory Affairs Lead (remote)

Corbus Pharmaceuticals

Atlassian Cloud

Salesforce

VideoJS

Google Analytics

Laurus Synthesis offers world-class contract development and manufacturing services. With strengths in flexi-scale drug substance manufacturing and phase-appropriate chemical and analytical development, Laurus Synthesis is well-positioned to meet all NCE drug substance needs of clients, from preclinical through to commercial manufacture.Innovative, robust and scalable chemistry is the core strength of Laurus Synthesis. We handle developmental candidates for clients at all stages of the drug lifecycle from route identification to custom synthesis and early clinical to commercialization. Our development and manufacturing teams maintain a tight focus on performance at scale, continuous process improvement, securing and de-risking supply chains to provide an efficient, compliant, cost-effective and long-term commercial drug substance solution.

Laurus Synthesis

Apache

Mobile Friendly

Bootstrap Framework

Cubist Pharmaceuticals is a bio pharmaceutical firm focused on building therapies for the treatment of  life-threatening infections.

Cubist Pharmaceuticals

AT&T DNS

Clifton Leigh

Director, Chemical Development at Deciphera Pharmaceuticals

Clifton Leigh's Professional Contact Details

Clifton Leigh's Current Company Details

Deciphera Pharmaceuticals

Clifton Leigh's Work History and Education

Frequently Asked Questions about Clifton Leigh

What company does Clifton Leigh work for?

What is Clifton Leigh's role at Deciphera Pharmaceuticals?

What is Clifton Leigh's email address?

What is Clifton Leigh's business email address?

What is Clifton Leigh's HQ phone number?

What industry does Clifton Leigh work in?

Who are Clifton Leigh's colleagues?

Colleagues at Deciphera Pharmaceuticals

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?